Maprolu: An effective antidepressant from Germany
Maprolu, also known as maprotiline, is an antidepressant developed in Germany. It belongs to the group of non-selective neuronal uptake inhibitors and is used to treat various forms of depression and other mental disorders.
Production and international name:
Maprolu is produced by the pharmaceutical company Hexal Pharma GmbH in Germany. The international name of this drug is maprotiline. It is also known by synonyms such as Ladiomil, Ludiomil, Ludiomil and Maprotibene.
Dosage forms and composition:
Maprolu is available in filmized tablets in various strengths: 10 mg, 25 mg, 50 mg and 75 mg. The active substance of the drug is maprotiline.
Indications for use:
The drug is used to treat various forms of depression, including endogenous, involutional, psychogenic, reactive and neurotic depression. It is also effective for depression accompanied by apathy, anxiety, irritability, as well as dysphoria and depressed mood. Maprolu can be used to treat psychosomatic and somatic disorders caused by depression and fear, as well as menopausal depression.
Contraindications:
Maprola is not recommended for patients with hypersensitivity to the drug, epilepsy and conditions characterized by increased convulsive activity. It is also contraindicated in the acute stage of myocardial infarction, closed-angle glaucoma, prostate adenoma, acute alcohol intoxication and during lactation. The use of the drug in pregnant women is possible only when the benefit to the mother outweighs the potential risk to the fetus, and its use requires careful monitoring and discontinuation of treatment at least 7 weeks before the expected date of birth.
Side effects:
Some of the side effects that may occur while taking maprolu include dry mouth, constipation, urinary retention, accommodation problems, orthostatic hypotension, muscle weakness, fatigue, drowsiness or insomnia, tachycardia, blood pressure fluctuations and allergic reactions.
Interaction with other drugs:
Maprolu may interact with various medications, so you should consult your doctor or pharmacist before starting treatment. It is not recommended to be taken together with monoamine oxidase inhibitors (MAOIs), antiepileptic drugs, antihistamines, alcohol and some other drugs.
Important information:
Maprola should be taken strictly as prescribed by your doctor. The dosage and duration of treatment are determined individually, based on the clinical situation and the patient's response to the drug. Self-medication or changing the dosage without consulting a doctor is not recommended.
Conclusions:
Maprolu (maprotiline) is an effective antidepressant from Germany that is used to treat various forms of depression and other mental disorders. It has neuronal uptake inhibitor properties and may help improve mood, reduce anxiety and other symptoms of depression. However, before starting treatment, you should consult your doctor to evaluate the indications, contraindications and possible side effects.